News Ohio is third state to fund Pear's digital therapeutics to t... A third US state has agreed to fund Pear Therapeutics’ digital therapeutics (DTx) to treat people with substance and opioid use disorders.
Partner Content Partner Content Top-Level industry professionals to speak at Pain Therapeuti... 2 weeks Pain Therapeutics Conference - expert speakers
Partner Content Partner Content Registration Opens for SMi’s 20th Annual Pain Therapeutics C... Registration Opens SMi’s Pain Therapeutics
News Washington State is latest to sue Janssen over opioid market... Washington State has become the latest to sue Johnson & Johnson over the way it marketed opioid painkillers, according to press reports.
News J&J brushes off concerns over talc, opioid and Risperdal lit... Johnson & Johnson has brushed off investors’ concerns over the many lawsuits it is facing, saying its legal team will overcome the litigation issues that have dominated headlines over t
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.